Fundraising Fox
Genomate
Cambridge, US · Founded 2022 · 1 known investors
Find your way into Genomate
Each arrow is one introduction. Sign up to fill in the first one.
Ask Stefano Galiasso to introduce you to ISTVAN PETAK
You →Stefano · together at University of Illinois Chicago →ISTVAN
Sign up to find every way you can get introduced to Genomate
- Your email: who you already know at Genomate, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Genomate team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Genomate Health develops an AI-powered clinical decision support system for precision oncology that analyzes a patient's molecular profile to produce evidence-based treatment rankings for physicians. Its Genomate platform combines oncology, genomics, and computational reasoning to support personalized cancer treatment decisions.
Founders & leadership
Genomate was founded in 2022 by ISTVAN PETAK.
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$10.4M disclosed across 3 rounds · 2022–2025
▶$2MraisedMar 2025 · 1 investors · Other Health CareRule 506(b)
- RICHARD SCHWABDirector
- JARED SCHRIEBERDirector
- ISTVAN PETAKExecutive Officer, Director
- SCOTT FRIEDMANDirector
- LASZLO MECHTLERDirector
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$5.7MraisedFeb 2025 · 7 investors · Other Health CareRule 506(b)
- SCOTT FRIEDMANDirector
- RICHARD SCHWABDirector
- LASZLO MECHTLERDirector
- JARED SCHRIEBERDirector
- ISTVAN PETAKExecutive Officer, Director
- Offering amount
- $5.7M
- Amount sold
- $5.7M
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$2.6MraisedFeb 2025 · 4 investors · Other Health CareRule 506(b)
- ISTVAN PETAKExecutive Officer, Director
- JARED SCHRIEBERDirector
- SCOTT FRIEDMANDirector
- LASZLO MECHTLERDirector
- RICHARD SCHWABDirector
- Offering amount
- $2.6M
- Amount sold
- $2.6M
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Genomate.
Frequently asked questions
- What does Genomate do?
- Genomate Health develops an AI-powered clinical decision support system for precision oncology that analyzes a patient's molecular profile to produce evidence-based treatment rankings for physicians. Its Genomate platform combines oncology, genomics, and computational reasoning to support personalized cancer treatment decisions.
- Who founded Genomate?
- Genomate was founded by ISTVAN PETAK in 2022.
- Who are Genomate's investors?
- Genomate's investors include Oktogon Ventures.
- How much funding has Genomate raised?
- Genomate has disclosed $10.4M raised across 3 rounds.
- Where is Genomate headquartered?
- Genomate is headquartered in Cambridge, US.